AstraZeneca PLC (AZN) — Cash Flow Reinvestment Rate
AstraZeneca PLC (AZN) has a Cash Flow Reinvestment Rate of 0.49x as of March 2026, reinvesting GBX1.63 Billion (capex GBX1.54 Billion plus investments GBX-93.00 Million) from operating cash flow of GBX3.36 Billion. Check earnings quality score of AstraZeneca PLC to evaluate the quality of earnings relative to operating cash generation.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
AstraZeneca PLC Cash Flow Reinvestment Rate (1990–2025)
Historical reinvestment intensity for AstraZeneca PLC across 36 annual periods. Explore AZN strategic capital deployment ratio to see how much of total assets are deployed in long-term investments.
Annual Cash Flow Reinvestment Rate for AstraZeneca PLC (1990–2025)
Year-by-year capital reinvestment analysis for AstraZeneca PLC. For live market cap and broader valuation context, see AstraZeneca PLC stock valuation.
| Year | Reinvestment Rate | Total Reinvested (GBX) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2025 | 0.41x | GBX6.00 Billion | GBX14.57 Billion | GBX5.91 Billion | ▼ -61.1% |
| 2024 | 1.06x | GBX12.57 Billion | GBX11.86 Billion | GBX4.59 Billion | ▲ +39.8% |
| 2023 | 0.76x | GBX7.84 Billion | GBX10.35 Billion | GBX3.78 Billion | ▲ +34.4% |
| 2022 | 0.56x | GBX5.53 Billion | GBX9.81 Billion | GBX2.57 Billion | ▲ +19.9% |
| 2021 | 0.47x | GBX2.81 Billion | GBX5.96 Billion | GBX2.20 Billion | ▼ -51.0% |
| 2020 | 0.96x | GBX4.61 Billion | GBX4.80 Billion | GBX2.61 Billion | ▲ +10.2% |
| 2019 | 0.87x | GBX2.58 Billion | GBX2.97 Billion | GBX2.46 Billion | ▲ +50.9% |
| 2018 | 0.58x | GBX1.51 Billion | GBX2.62 Billion | GBX1.37 Billion | ▼ -0.1% |
| 2017 | 0.58x | GBX2.07 Billion | GBX3.58 Billion | GBX1.62 Billion | ▼ -61.9% |
| 2016 | 1.52x | GBX6.28 Billion | GBX4.14 Billion | GBX2.31 Billion | ▲ +64.6% |
| 2015 | 0.92x | GBX3.06 Billion | GBX3.32 Billion | GBX2.79 Billion | ▲ +127.4% |
| 2014 | 0.41x | GBX2.86 Billion | GBX7.06 Billion | GBX2.75 Billion | ▲ +45.7% |
| 2013 | 0.28x | GBX2.06 Billion | GBX7.40 Billion | GBX2.06 Billion | ▼ -58.2% |
| 2012 | 0.66x | GBX4.62 Billion | GBX6.95 Billion | GBX4.62 Billion | ▲ +300.9% |
| 2011 | 0.17x | GBX1.30 Billion | GBX7.82 Billion | GBX1.30 Billion | ▼ -26.8% |
| 2010 | 0.23x | GBX2.42 Billion | GBX10.68 Billion | GBX2.42 Billion | ▼ -10.0% |
| 2009 | 0.25x | GBX2.96 Billion | GBX11.74 Billion | GBX2.96 Billion | ▼ -45.5% |
| 2008 | 0.46x | GBX4.04 Billion | GBX8.74 Billion | GBX4.04 Billion | ▲ +106.7% |
| 2007 | 0.22x | GBX1.68 Billion | GBX7.51 Billion | GBX1.68 Billion | ▲ +28.4% |
| 2006 | 0.17x | GBX1.34 Billion | GBX7.69 Billion | GBX1.34 Billion | ▲ +19.9% |
| 2005 | 0.15x | GBX979.00 Million | GBX6.74 Billion | GBX979.00 Million | ▲ +113.1% |
| 2004 | 0.07x | GBX332.00 Million | GBX4.87 Billion | GBX332.00 Million | ▼ -81.8% |
| 2003 | 0.38x | GBX1.28 Billion | GBX3.42 Billion | GBX1.28 Billion | ▲ +35.4% |
| 2002 | 0.28x | GBX1.34 Billion | GBX4.83 Billion | GBX1.34 Billion | ▼ -66.8% |
| 2001 | 0.84x | GBX2.26 Billion | GBX2.71 Billion | GBX2.26 Billion | ▲ +33.7% |
| 2000 | 0.63x | GBX1.46 Billion | GBX2.34 Billion | GBX1.46 Billion | ▼ -79.4% |
| 1999 | 3.03x | GBX2.75 Billion | GBX908.55 Million | GBX2.75 Billion | ▲ +215.4% |
| 1998 | 0.96x | GBX844.88 Million | GBX879.74 Million | GBX844.88 Million | ▼ -5.0% |
| 1997 | 1.01x | GBX755.47 Million | GBX747.21 Million | GBX755.47 Million | ▲ +24.7% |
| 1996 | 0.81x | GBX638.76 Million | GBX787.75 Million | GBX638.76 Million | ▲ +10.2% |
| 1995 | 0.74x | GBX431.11 Million | GBX585.64 Million | GBX431.11 Million | ▼ -6.5% |
| 1994 | 0.79x | GBX492.47 Million | GBX625.36 Million | GBX492.47 Million | ▲ +20.0% |
| 1993 | 0.66x | GBX462.99 Million | GBX705.58 Million | GBX462.99 Million | ▼ -66.7% |
| 1992 | 1.97x | GBX406.47 Million | GBX206.27 Million | GBX406.47 Million | ▲ +158.3% |
| 1991 | 0.76x | GBX385.46 Million | GBX505.22 Million | GBX385.46 Million | ▲ +13.9% |
| 1990 | 0.67x | GBX540.10 Million | GBX806.30 Million | GBX540.10 Million | — |